# Eisai completes new oral solid-dose plant in Suzhou, China

Eisai's Chinese subsidiary completed a new oral solid dose production facility and administration building at its Suzhou plant in the Suzhou Industrial Park. The facility has capacity for approximately 3 billion tablets formulation and 5 billion tablets packaging per year, doubling the capacity of the current plant.

- Type: New facility
- Announced: 2018-01-15
- Where: Suzhou Industrial Park, Suzhou, China
- Starts operating: Q4 2018
- Status: completed
- Capacity: 3 billion tablets formulation and 5 billion tablets packaging per year
- Products: oral solid dose pharmaceuticals, Methycobal, Aricept, Pariet

## Companies

- [Eisai](https://endata.com/companies/29392.md)

## Sources

- [genengnews.com](https://www.genengnews.com/news/eisai-completes-new-oral-solid-dose-plant-in-china/), 2018-01-15: "Eisai said it sought to strengthen its in-house domestic production system in China, and expand its stable supply chain of pharmaceuticals, through the completion of the OSD production facility at the new Suzhou plant."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.